Quantbot Technologies LP Athenex, Inc. Transaction History

Quantbot Technologies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$2.97 - $4.84 $98,604 - $160,688	-33,200 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.71 - $5.13 $28,938 - $40,014	7,800 Added 30.71%	33,200 $153,000
Q1 2021 May 14, 2021	BUY	$4.08 - $14.75 $103,632 - $374,650	25,400 New	25,400 $109,000
Q1 2020 May 13, 2020	SELL	$5.71 - $15.85 $77,656 - $215,560	-13,600 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$9.6 - $17.75 $130,560 - $241,400	13,600 New	13,600 $207,000
Q3 2019 Nov 12, 2019	SELL	$12.16 - $21.0 $82,688 - $142,800	-6,800 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$9.44 - $19.8 $64,192 - $134,640	6,800 New	6,800 $134,000
Q2 2018 Aug 13, 2018	SELL	$15.88 - $19.5 $72,190 - $88,647	-4,546 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$13.53 - $17.47 $61,507 - $79,418	4,546 New	4,546 $77,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.